Joint effect of hepatic steatosis index and triglyceride glucose index on cardio-renal outcomes: a real-world study
Journal of Diabetes & Metabolic Disorders · 09.05.2026 · 25 (1)
DOI: 10.1007/s40200-026-01937-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Diabetes & Metabolic Disorders, online erschienen am 09.05.2026. Verfasst von Yun Shen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Pennington Biomedical Research Center, Baton Rouge, LA USA. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCCDPHP CDC HHS, NIGMS NIH HHS, National Institute of General Medical Sciences.
Abstract (Originalsprache)
Objective
Hepatic steatosis index (HSI) and triglyceride glucose (TyG) index are emerging markers associated with metabolic health and cardiovascular risk. Their combined effects on cardio-renal outcomes remain poorly understood. This study evaluated the joint effect of HSI and TyG index on cardio-renal outcomes in a real-world population.
Methods
We analyzed 16,109 participants, stratified by tertiles of TyG index and HSI groups (≤ 36 vs. >36). Cardio-renal outcomes included composite major adverse cardiovascular events (MACE: cerebrovascular events, coronary artery disease, heart failure, myocardial infarction) and renal events (eGFR decline ≥ 50%, end-stage kidney disease [ESKD], proteinuria). Hazard ratios (HRs) were calculated using multivariable Cox proportional hazards models adjusted for demographics and clinical covariates.
Results
Higher TyG tertiles were associated with a significantly increased risk of composite cardio-renal outcomes (HR for tertile 3 vs. tertile 1: 1.58; 95% CI: 1.37–1.83). Subgroup analysis showed that individuals with HSI > 36 and TyG tertile 3 had the highest risks for composite MACE (HR: 1.62; 95% CI: 1.34–1.96) and composite renal outcomes (HR: 3.13; 95% CI: 2.10–4.68) compared with other subgroups. Both higher TyG and HSI levels showed a particularly strong association with proteinuria (HR for HSI > 36 and TyG tertile 3: 3.69; 95% CI: 2.26–6.02).
Conclusions
The combined assessment of HSI and TyG index provides a valuable tool for identifying individuals at high risk for cardio-renal outcomes. These findings highlighted the importance of metabolic markers in predicting complications and underscore the need for early interventions targeting these populations.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Pennington Biomedical Research Center, Baton Rouge, LA USA.
- Pennington Biomedical Research Center, Baton Rouge, LA 70808 USA.
- Celia Scott Weatherhead School of Public Health and Tropical Medicine, Tulane University, New Orleans, LA USA.
- School of Medicine, Tulane University, New Orleans, LA USA.
- Louisiana Public Health Institute, New Orleans, LA USA.
- Ochsner Clinical School - University of Queensland, New Orleans, LA USA.
Förderung
- NCCDPHP CDC HHS
- NIGMS NIH HHS
- National Institute of General Medical Sciences
- National Centers for Disease Control and Prevention and Health Promotion
Zitieren
APA
Shen, Y., Shi, L., Fonseca, V., Nauman, E., Price-Haywood, E., & Hu, G. (2026). Joint effect of hepatic steatosis index and triglyceride glucose index on cardio-renal outcomes: a real-world study. Journal of Diabetes & Metabolic Disorders, 25(1). https://doi.org/10.1007/s40200-026-01937-0
Vancouver
Shen Y, Shi L, Fonseca V, Nauman E, Price-Haywood E, Hu G. Joint effect of hepatic steatosis index and triglyceride glucose index on cardio-renal outcomes: a real-world study. Journal of Diabetes & Metabolic Disorders. 2026;25(1). doi:10.1007/s40200-026-01937-0
BibTeX
@article{Shen2026,
author = {Shen, Yun and Shi, Lizheng and Fonseca, Vivian and Nauman, Elizabeth and Price-Haywood, Eboni and Hu, Gang},
title = {Joint effect of hepatic steatosis index and triglyceride glucose index on cardio-renal outcomes: a real-world study},
journal = {Journal of Diabetes & Metabolic Disorders},
year = {2026},
volume = {25},
number = {1},
doi = {10.1007/s40200-026-01937-0}
}
EUVIMED